Inovalon Holdings, Inc. (NASDAQ:INOV) will issue its quarterly earnings data after the market closes on Tuesday, October 31st. Inovalon Holdings has set its FY17 guidance at $0.29-$0.32 EPS.

Inovalon Holdings (NASDAQ:INOV) last posted its earnings results on Wednesday, August 2nd. The technology company reported $0.08 EPS for the quarter, topping the Zacks’ consensus estimate of $0.07 by $0.01. The business had revenue of $110.60 million during the quarter, compared to analyst estimates of $108.73 million. Inovalon Holdings had a return on equity of 5.17% and a net margin of 4.13%. The company’s quarterly revenue was down 10.7% compared to the same quarter last year. During the same quarter last year, the company earned $0.14 EPS. On average, analysts expect Inovalon Holdings to post $0.25 EPS for the current fiscal year and $0.31 EPS for the next fiscal year.

Shares of Inovalon Holdings, Inc. (NASDAQ:INOV) opened at 16.75 on Tuesday. The firm has a 50 day moving average price of $16.81 and a 200-day moving average price of $16.81. Inovalon Holdings, Inc. has a 12-month low of $8.60 and a 12-month high of $17.80. The company has a market cap of $2.44 billion, a price-to-earnings ratio of 140.76 and a beta of 1.29.

WARNING: “Inovalon Holdings, Inc. (INOV) Set to Announce Quarterly Earnings on Tuesday” was first published by American Banking News and is the property of of American Banking News. If you are viewing this news story on another site, it was stolen and reposted in violation of international trademark & copyright law. The original version of this news story can be read at

INOV has been the topic of several research reports. BidaskClub downgraded Inovalon Holdings from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, July 12th. ValuEngine raised Inovalon Holdings from a “sell” rating to a “hold” rating in a research report on Wednesday, September 6th. Morgan Stanley raised Inovalon Holdings from an “underweight” rating to an “equal weight” rating and increased their price target for the stock from $9.00 to $14.00 in a research report on Tuesday, September 12th. KeyCorp reaffirmed a “hold” rating on shares of Inovalon Holdings in a research report on Tuesday, September 12th. Finally, TheStreet raised Inovalon Holdings from a “d+” rating to a “c-” rating in a research report on Thursday, October 5th. One research analyst has rated the stock with a sell rating, eight have assigned a hold rating and one has issued a buy rating to the company. Inovalon Holdings has a consensus rating of “Hold” and a consensus price target of $14.00.

In related news, CEO Keith R. Dunleavy purchased 62,000 shares of the firm’s stock in a transaction that occurred on Wednesday, September 13th. The shares were purchased at an average cost of $16.38 per share, with a total value of $1,015,560.00. Following the purchase, the chief executive officer now owns 270,000 shares of the company’s stock, valued at approximately $4,422,600. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Company insiders own 48.28% of the company’s stock.

About Inovalon Holdings

Inovalon Holdings, Inc (Inovalon) is a technology company. The Company provides cloud-based platforms empowering a data-driven transformation from volume-based to value-based models to the healthcare industry. Leveraging large-scale data interconnectivity capabilities, unparalleled proprietary data sets, advanced analytics, data-driven intervention systems, and subject matter expertise, Inovalon enables the assessment and improvement of clinical and quality outcomes and financial performance across the healthcare ecosystem.

Earnings History for Inovalon Holdings (NASDAQ:INOV)

Receive News & Ratings for Inovalon Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inovalon Holdings Inc. and related companies with's FREE daily email newsletter.